Why Has Breast Cancer Screening Failed to Decrease the Incidence of de Novo Stage IV Disease?
<i>Background</i>: Despite screening mammography, the incidence of Stage IV breast cancer (BC) at diagnosis has not decreased over the past four decades. We previously found that many BCs are small due to favorable biology rather than early detection. This study compared the biology of S...
Main Authors: | Danielle R. Heller, Alexander S. Chiu, Kaitlin Farrell, Brigid K. Killelea, Donald R. Lannin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/4/500 |
Similar Items
-
Variation in Treatment Patterns of Patients with Early-Onset Gastric Cancer
by: Michael LaPelusa, et al.
Published: (2022-07-01) -
Defining targets to improve care delivery for T4 larynx squamous cell carcinoma
by: Catherine H. Frenkel, et al.
Published: (2022-12-01) -
Racial Differences in Incident Genitourinary Cancer Cases Captured in the National Cancer Database
by: Dylan T. Wolff, et al.
Published: (2021-06-01) -
Anal adenocarcinoma: Treatment outcomes and trends in a rare disease entity
by: Rodney E. Wegner, et al.
Published: (2019-07-01) -
Racial/Ethnic Differences and Trends in Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer
by: Sung Jun Ma, et al.
Published: (2022-01-01)